MedTech News
Novel mRNA-based therapy shows promise in heart regeneration after heart attack
Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as cardiomyocytes—and the heart’s limited regenerative capacity often lead to chronic heart failure. Current treatment strategies manage symptoms but do not repair the underlying damage.
Scientists reprogram stem cells to create renewable cancer-fighting T cells
In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune system’s most powerful cancer-killing agents.
Novel radioimmunotherapy eradicates cancer stem cells in ovarian cancer model
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard.
Researchers harness AI-powered protein design to enhance T-cell based immunotherapies
A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in T-cell development and function.
Ushering in a new era of suture-free tissue reconstruction for better healing
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.
EvoEndo earns expanded FDA clearance for gastroscope
EvoEndo announced today that it received expanded FDA clearance for its Model LE gastroscope, covering patients of all ages.
New treatment could reduce brain damage from stroke, study in mice shows
Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.
Blood test analyzes immune protein changes to detect early-stage tumors and guide treatment
Current methods for cancer diagnosis are based on identifying biomarkers—molecules that reveal a particular state or process in the body—produced by the tumor or associated proteins. Not surprisingly, these markers are more abundant once the tumor has already developed significantly. And the more advanced the tumor, the more difficult it is to find effective treatment options.